117 related articles for article (PubMed ID: 8205750)
1. Inhibitory effects of neuropeptide Y on splanchnic glycogenolysis and renin release in humans.
Ahlborg G; Lundberg JM
Clin Physiol; 1994 Mar; 14(2):187-96. PubMed ID: 8205750
[TBL] [Abstract][Full Text] [Related]
2. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man.
Ahlborg G; Weitzberg E; Sollevi A; Lundberg JM
Acta Physiol Scand; 1992 Jun; 145(2):139-49. PubMed ID: 1636443
[TBL] [Abstract][Full Text] [Related]
3. Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans.
Ahlborg G; Weitzberg E; Lundberg JM
Clin Physiol; 1992 Mar; 12(2):145-53. PubMed ID: 1582134
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 infusion reduces splanchnic glucose production in humans.
Ahlborg G; Weitzberg E; Lundberg JM
J Appl Physiol (1985); 1994 Jul; 77(1):121-6. PubMed ID: 7961223
[TBL] [Abstract][Full Text] [Related]
5. Splanchnic release of neuropeptide Y during prolonged exercise with and without beta-adrenoceptor blockade in healthy man.
Ahlborg G; Lundberg JM
Clin Physiol; 1991 Jul; 11(4):343-51. PubMed ID: 1680600
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of epinephrine-induced glucose intolerance in normal humans.
Saccà L; Vigorito C; Cicala M; Ungaro B; Sherwin RS
J Clin Invest; 1982 Feb; 69(2):284-93. PubMed ID: 7035494
[TBL] [Abstract][Full Text] [Related]
7. Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects.
Eriksson LS; Hagenfeldt L; Mutt V; Wahren J
Peptides; 1989; 10(2):481-4. PubMed ID: 2666962
[TBL] [Abstract][Full Text] [Related]
8. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
[TBL] [Abstract][Full Text] [Related]
9. Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans.
Björkman O; Felig P; Wahren J
Clin Physiol; 1984 Jun; 4(3):227-41. PubMed ID: 6146427
[TBL] [Abstract][Full Text] [Related]
10. Insulin secretion in rats: effects of neuropeptide Y and noradrenaline.
Pettersson M; Ahrén B
Diabetes Res; 1990 Jan; 13(1):35-42. PubMed ID: 2097094
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver.
Lüers C; Gardemann A; Miura H; Jungermann K
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):455-62. PubMed ID: 10784001
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and vascular effects of circulating endothelin-1 during moderately heavy prolonged exercise.
Ahlborg G; Weitzberg E; Lundberg J
J Appl Physiol (1985); 1995 Jun; 78(6):2294-300. PubMed ID: 7665432
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic blood flow and hepatic glucose production in exercising humans: role of renin-angiotensin system.
Bergeron R; Kjaer M; Simonsen L; Bülow J; Skovgaard D; Howlett K; Galbo H
Am J Physiol Regul Integr Comp Physiol; 2001 Dec; 281(6):R1854-61. PubMed ID: 11705770
[TBL] [Abstract][Full Text] [Related]
14. Effect of adrenaline on exchange of glucose in leg tissues and splanchnic area. A comparison with the metabolic response to surgical stress.
Håkanson E; Rutberg H; Jorfeldt L
Clin Physiol; 1986 Oct; 6(5):439-51. PubMed ID: 3780167
[TBL] [Abstract][Full Text] [Related]
15. Effects of neuropeptide Y on insulin and glucagon secretion in the pig.
Ahrén B; Mårtensson H; Falck B
Neuropeptides; 1991 Sep; 20(1):49-55. PubMed ID: 1791925
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
[TBL] [Abstract][Full Text] [Related]
17. Renal and systemic plasma immunoreactive neuropeptide Y and calcitonin gene-related peptide responses to mental stress and adrenaline in humans.
Tidgren B; Theodorsson E; Hjemdahl P
Clin Physiol; 1991 Jan; 11(1):9-19. PubMed ID: 2019081
[TBL] [Abstract][Full Text] [Related]
18. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
Rudehill A; Lundberg JM; Sollevi A; Hjemdahl P
Acta Anaesthesiol Scand; 1987 Feb; 31(2):132-8. PubMed ID: 3564869
[TBL] [Abstract][Full Text] [Related]
19. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
[TBL] [Abstract][Full Text] [Related]
20. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
Pernow J; Lundberg JM; Kaijser L; Hjemdahl P; Theodorsson-Norheim E; Martinsson A; Pernow B
Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
